Go Pro

Astrana Health (ASTH) Competitors

Astrana Health logo
$35.56 0.00 (0.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$35.54 -0.02 (-0.04%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ASTH vs. HQY, ETSY, STN, APLD, and BILI

Should you buy Astrana Health stock or one of its competitors? MarketBeat compares Astrana Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Astrana Health include HealthEquity (HQY), Etsy (ETSY), Stantec (STN), Applied Digital (APLD), and Bilibili (BILI).

How does Astrana Health compare to HealthEquity?

Astrana Health (NASDAQ:ASTH) and HealthEquity (NASDAQ:HQY) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, media sentiment, profitability, dividends, risk and institutional ownership.

In the previous week, HealthEquity had 6 more articles in the media than Astrana Health. MarketBeat recorded 10 mentions for HealthEquity and 4 mentions for Astrana Health. HealthEquity's average media sentiment score of 1.74 beat Astrana Health's score of 0.77 indicating that HealthEquity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Astrana Health
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
HealthEquity
10 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

HealthEquity has a net margin of 17.25% compared to Astrana Health's net margin of 0.86%. HealthEquity's return on equity of 14.75% beat Astrana Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Astrana Health0.86% 9.22% 3.54%
HealthEquity 17.25%14.75%9.22%

Astrana Health currently has a consensus target price of $47.86, suggesting a potential upside of 34.58%. HealthEquity has a consensus target price of $110.93, suggesting a potential upside of 10.26%. Given Astrana Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Astrana Health is more favorable than HealthEquity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
HealthEquity
1 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.77

Astrana Health has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market.

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 20.3% of Astrana Health shares are held by insiders. Comparatively, 1.6% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

HealthEquity has lower revenue, but higher earnings than Astrana Health. HealthEquity is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Astrana Health$3.18B0.62$22.49M$0.6158.30
HealthEquity$1.34B6.29$215.20M$2.6737.68

Summary

HealthEquity beats Astrana Health on 10 of the 16 factors compared between the two stocks.

How does Astrana Health compare to Etsy?

Astrana Health (NASDAQ:ASTH) and Etsy (NYSE:ETSY) are related companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment.

Etsy has lower revenue, but higher earnings than Astrana Health. Etsy is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Astrana Health$3.18B0.62$22.49M$0.6158.30
Etsy$2.88B2.69$162.98M$2.4034.05

Astrana Health has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, Etsy has a beta of 1.84, suggesting that its stock price is 84% more volatile than the broader market.

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 99.5% of Etsy shares are held by institutional investors. 20.3% of Astrana Health shares are held by insiders. Comparatively, 2.5% of Etsy shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Etsy had 14 more articles in the media than Astrana Health. MarketBeat recorded 18 mentions for Etsy and 4 mentions for Astrana Health. Etsy's average media sentiment score of 0.91 beat Astrana Health's score of 0.77 indicating that Etsy is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Astrana Health
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Etsy
8 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Etsy has a net margin of 9.94% compared to Astrana Health's net margin of 0.86%. Astrana Health's return on equity of 9.22% beat Etsy's return on equity.

Company Net Margins Return on Equity Return on Assets
Astrana Health0.86% 9.22% 3.54%
Etsy 9.94%-28.60%11.93%

Astrana Health presently has a consensus price target of $47.86, indicating a potential upside of 34.58%. Etsy has a consensus price target of $75.36, indicating a potential downside of 7.79%. Given Astrana Health's stronger consensus rating and higher probable upside, research analysts plainly believe Astrana Health is more favorable than Etsy.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Etsy
1 Sell rating(s)
20 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.34

Summary

Etsy beats Astrana Health on 11 of the 17 factors compared between the two stocks.

How does Astrana Health compare to Stantec?

Stantec (NYSE:STN) and Astrana Health (NASDAQ:ASTH) are related companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

Stantec has a net margin of 5.92% compared to Astrana Health's net margin of 0.86%. Stantec's return on equity of 19.37% beat Astrana Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Stantec5.92% 19.37% 8.03%
Astrana Health 0.86%9.22%3.54%

Stantec has a beta of 1, suggesting that its stock price has a similar volatility profile to the broader market.Comparatively, Astrana Health has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market.

63.9% of Stantec shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 0.5% of Stantec shares are held by company insiders. Comparatively, 20.3% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Stantec has higher revenue and earnings than Astrana Health. Stantec is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stantec$8.29B0.96$343.11M$3.1222.62
Astrana Health$3.18B0.62$22.49M$0.6158.30

In the previous week, Stantec had 7 more articles in the media than Astrana Health. MarketBeat recorded 11 mentions for Stantec and 4 mentions for Astrana Health. Stantec's average media sentiment score of 1.09 beat Astrana Health's score of 0.77 indicating that Stantec is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stantec
8 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Astrana Health
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stantec presently has a consensus target price of $175.00, indicating a potential upside of 147.95%. Astrana Health has a consensus target price of $47.86, indicating a potential upside of 34.58%. Given Stantec's higher possible upside, equities analysts clearly believe Stantec is more favorable than Astrana Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stantec
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78

Summary

Stantec beats Astrana Health on 12 of the 16 factors compared between the two stocks.

How does Astrana Health compare to Applied Digital?

Applied Digital (NASDAQ:APLD) and Astrana Health (NASDAQ:ASTH) are related companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

Applied Digital has a beta of 5.67, suggesting that its stock price is 467% more volatile than the broader market. Comparatively, Astrana Health has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market.

65.7% of Applied Digital shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 9.5% of Applied Digital shares are owned by company insiders. Comparatively, 20.3% of Astrana Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Astrana Health has a net margin of 0.86% compared to Applied Digital's net margin of -37.78%. Astrana Health's return on equity of 9.22% beat Applied Digital's return on equity.

Company Net Margins Return on Equity Return on Assets
Applied Digital-37.78% -16.42% -4.00%
Astrana Health 0.86%9.22%3.54%

Astrana Health has higher revenue and earnings than Applied Digital. Applied Digital is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied Digital$611.31M13.06-$244M-$0.89N/A
Astrana Health$3.18B0.62$22.49M$0.6158.30

Applied Digital currently has a consensus price target of $67.15, indicating a potential upside of 145.16%. Astrana Health has a consensus price target of $47.86, indicating a potential upside of 34.58%. Given Applied Digital's stronger consensus rating and higher probable upside, equities analysts plainly believe Applied Digital is more favorable than Astrana Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Applied Digital
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
3 Strong Buy rating(s)
3.00
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78

In the previous week, Applied Digital had 41 more articles in the media than Astrana Health. MarketBeat recorded 45 mentions for Applied Digital and 4 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.77 beat Applied Digital's score of 0.69 indicating that Astrana Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Applied Digital
15 Very Positive mention(s)
10 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive
Astrana Health
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Astrana Health beats Applied Digital on 9 of the 17 factors compared between the two stocks.

How does Astrana Health compare to Bilibili?

Bilibili (NASDAQ:BILI) and Astrana Health (NASDAQ:ASTH) are related companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

Bilibili has a beta of 0.71, meaning that its share price is 29% less volatile than the broader market. Comparatively, Astrana Health has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

16.1% of Bilibili shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 22.2% of Bilibili shares are held by insiders. Comparatively, 20.3% of Astrana Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Bilibili currently has a consensus price target of $30.78, indicating a potential upside of 61.14%. Astrana Health has a consensus price target of $47.86, indicating a potential upside of 34.58%. Given Bilibili's higher probable upside, research analysts plainly believe Bilibili is more favorable than Astrana Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bilibili
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.78
Astrana Health
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78

Bilibili has a net margin of 4.58% compared to Astrana Health's net margin of 0.86%. Bilibili's return on equity of 10.81% beat Astrana Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Bilibili4.58% 10.81% 4.04%
Astrana Health 0.86%9.22%3.54%

Bilibili has higher revenue and earnings than Astrana Health. Bilibili is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bilibili$4.34B1.83$170.67M$0.4542.44
Astrana Health$3.18B0.62$22.49M$0.6158.30

In the previous week, Astrana Health had 2 more articles in the media than Bilibili. MarketBeat recorded 4 mentions for Astrana Health and 2 mentions for Bilibili. Bilibili's average media sentiment score of 0.91 beat Astrana Health's score of 0.77 indicating that Bilibili is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bilibili
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Astrana Health
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Bilibili beats Astrana Health on 10 of the 15 factors compared between the two stocks.

Get Astrana Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ASTH vs. The Competition

MetricAstrana HealthHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.98B$9.89B$6.86B$12.42B
Dividend YieldN/A2.53%2.59%10.03%
P/E Ratio58.3025.44282.3024.66
Price / Sales0.624.74561.3476.65
Price / Cash12.6426.2428.6046.71
Price / Book2.525.1410.986.07
Net Income$22.49M$311.05M$3.49B$347.99M
7 Day Performance-6.89%-1.05%-0.60%-0.44%
1 Month Performance-27.68%-1.61%-5.20%-4.81%
1 Year Performance64.86%26.23%62.01%18.61%

Astrana Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ASTH
Astrana Health
4.4122 of 5 stars
$35.56
flat
$47.86
+34.6%
+64.9%$1.98B$3.18B58.303,000
HQY
HealthEquity
4.1042 of 5 stars
$101.24
+2.2%
$110.93
+9.6%
+10.5%$8.28B$1.31B37.922,814
ETSY
Etsy
2.625 of 5 stars
$86.80
+3.5%
$75.36
-13.2%
N/A$7.96B$2.88B36.172,375
STN
Stantec
4.6706 of 5 stars
$71.86
+1.8%
$175.00
+143.5%
-35.0%$7.93B$5.83B23.0334,000
APLD
Applied Digital
3.5407 of 5 stars
$26.62
+0.9%
$67.15
+152.3%
+118.8%$7.54B$611.31MN/A121

Related Companies and Tools


This page (NASDAQ:ASTH) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners